2020 Annual Meeting | C157 - Cerebrovascular Disease 2: Update on Guidance-based Diagnosis and Management of Hemorrhagic Stroke

Date Tuesday 04/28/20

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Andrew M. Naidech, MD, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Participants will be able tol appropritely prescribe medications to reduce hematoma expansion, prevent complications, and reduce blood pressure to evidence-based targets.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Advanced Practice Provider, Neurohospitalist

Recommended Audience Fellow, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic

Event Timeline
03:30 PM - 04:15 PM	Speaker	Stanching the Bleeding: Reversing Anticoagulation in Acute ICH Tiffany Chang, MD
04:15 PM - 05:00 PM	Speaker	Take the Pressure Off: Blood Pressure Goals in Acute ICH Kevin N. Sheth, MD, FAAN
05:00 PM - 05:30 PM	Speaker	Do No Harm: Balancing Risks and Benefits for Prophylactic Seizure Medications Andrew M. Naidech, MD, FAAN

Faculty Disclosures
Andrew M. Naidech, MD, FAAN	The institution of Dr. Naidech has received research support from NIH. Dr. Naidech has received publishing royalties from a publication relating to health care.
Tiffany Chang, MD	Dr. Chang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Football League.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.

��ɫ��

��ɫ��